Literature DB >> 7521086

The early events of oxygen and glucose deprivation: setting the scene for neuronal death?

R L Martin1, H G Lloyd, A I Cowan.   

Abstract

It is generally thought that neuronal death caused by a reduction in oxygen or glucose supply, or both, occurs as a result of massive increases in the extracellular concentrations of excitatory amino acid neurotransmitters, particularly glutamate. A pertinent question is what happens before this increase, because measures which prevent extracellular accumulation of glutamate could have potential for clinical use in, for example, management of acute stroke. This article will review the major pathophysiological responses which occur up until the time of accumulation of glutamate. Withdrawal of energy substrate quickly leads to modest changes in membrane potential and intracellular and extracellular ion concentrations. Depression of action-potential-dependent synaptic transmission occurs a little later and might, in part, reflect actions of adenosine. Increases in the extracellular concentration of excitatory amino acids to neurotoxic levels take place only as membrane potential falls rapidly towards 0mV, coincident with massive changes in ion gradients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521086     DOI: 10.1016/0166-2236(94)90008-6

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  73 in total

1.  ATP inhibition of a mouse brain large-conductance K+ (mslo) channel variant by a mechanism independent of protein phosphorylation.

Authors:  A G Clark; S K Hall; M J Shipston
Journal:  J Physiol       Date:  1999-04-01       Impact factor: 5.182

2.  Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release.

Authors:  H Hu; L R Shao; S Chavoshy; N Gu; M Trieb; R Behrens; P Laake; O Pongs; H G Knaus; O P Ottersen; J F Storm
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

3.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

4.  Dissipation of transmembrane potassium gradient is the main cause of cerebral ischemia-induced depolarization in astrocytes and neurons.

Authors:  Yixing Du; Wei Wang; Anthony D Lutton; Conrad M Kiyoshi; Baofeng Ma; Anne T Taylor; John W Olesik; Dana M McTigue; Candice C Askwith; Min Zhou
Journal:  Exp Neurol       Date:  2018-02-03       Impact factor: 5.330

5.  Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons.

Authors:  P Calabresi; C M Ascone; D Centonze; A Pisani; G Sancesario; V D'Angelo; G Bernardi
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

Review 6.  Hydrogels for brain repair after stroke: an emerging treatment option.

Authors:  Lina Ratiba Nih; Stanley Thomas Carmichael; Tatiana Segura
Journal:  Curr Opin Biotechnol       Date:  2016-05-07       Impact factor: 9.740

7.  Neuronal mechanisms of the anoxia-induced network oscillations in the rat hippocampus in vitro.

Authors:  V Dzhala; I Khalilov; Y Ben-Ari; R Khazipov
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

8.  L-type Ca2+ channels in inspiratory neurones of mice and their modulation by hypoxia.

Authors:  S L Mironov; D W Richter
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

9.  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.

Authors:  C Heurteaux; I Lauritzen; C Widmann; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Action of adenosine receptor antagonists on hypoxia-induced effects in the rat hippocampus in vitro.

Authors:  M D Croning; T S Zetterström; D G Grahame-Smith; N R Newberry
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.